1 Department of Biochemistry, McGill University, McIntyre Medical Building, Montreal, Quebec, Canada H3G 1Y6
2 Laboratoire de Virologie Moléculaire et Structurale, CNRS, 1 Avenue de la Terrasse, 91198 Gif-sur-Yvette, France
3 Laboratorie de Virologie UPRES-EA1156, Institut de Biologie, Centre Hospitalier Regional Universitaire de Nantes, Rue Quai Moncousu 9, 44093 Nantes, France
4 Departamento de Técnicas Nucleares Aplicadas, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Igua 4225, 11400 Montevideo, Uruguay
Correspondence
Mauro Costa-Mattioli
mauro.costa-mattioli{at}mail.mcgill.ca
![]() |
ABSTRACT |
---|
Published ahead of print on 25 September 2003 as DOI 10.1099/vir.0.19532-0.
![]() |
Incidence, morbidity and mortality |
---|
Transmission occurs mainly through the faecaloral route where insufficient sanitation or poor hygienic conditions favour the pollution of water and food, especially shellfish (Hadler et al., 1980). Moreover, 63 % of the total number of viral hepatitis cases reported in 1998 were associated to hepatitis A (CDC, 1999
), but the true incidence of hepatitis A is thought to be much higher as the disease very often evolves without specific symptoms (an-icteric) and consequently goes undetected. Residence in correctional facilities, employment in or attendance at day-care centres for children, male homosexuality and travel to countries with poor sanitation are all risk factors.
In Canada, between 1000 and 3000 cases of hepatitis are reported every year. Hepatitis A accounts for 2540 % of all cases of acute hepatitis, with a variable incidence rate of 4·411·2 per 100 000 individuals. One in four cases requires hospitalization and the mortality rate among hospitalized adult cases has been estimated at about 0·15 %.
Travellers account for 1015 % of all reported cases of hepatitis, with an annual estimated rate of 3·67·2 per 100 individuals. Epidemiological studies indicate that the morbidity and mortality rate of hepatitis A among travellers is 500 times higher than those of cholera, 150 times higher than poliomyelitis, 10 times those of typhoid fever and three times higher than hepatitis B (Lenfant, 1994).
Systematic immunological surveys indicate that in South America over 90 % of the low-income population bears serological evidence of infection at the age of 18, and hepatitis A is responsible for more than 50 % of all acute hepatitis cases reported to national reference centres (Abuzwaida et al., 1987; Gaspar et al., 1992
; Montano, 2002
).
In southern Europe and the Mediterranean, about 90 % of the population bears antibodies against HAV, whereas less than 3 % of Scandinavians appear to have had contact with the virus (Frosner et al., 1979; Flehmig, 1980
; Daemer et al., 1981
; Mele et al., 1986
).
The cost of a non-complicated case of hepatitis A in France amounts to about \#8364; 300 (and there are between 30 000 and 50 000 new cases per year), whereas a fulminating case costs about \#8364; 6 000 and every year between 50 and 60 cases are reported. In Italy, after a few years of decline, hepatitis A re-emerged, with 11 000 cases reported in the Puglia region (Germinario et al., 2000).
The current trend of migration of large numbers of nationals from developing countries into the EU is bound to bring new variants of HAV and this should stress the need of simple, reliable and cheap methods for detecting antigenically unrelated variants both in the environment and in pathological specimens.
![]() |
The virus |
---|
HAV is a non-enveloped, 7·5 kb positive-stranded RNA virus (Hollinger & Emerson, 2001). Like all picornaviruses, the genome can be defined into three distinct regions (Fig. 1
). The 5' UTR contains an extensive secondary structure required for cap-independent translation and is covalently linked at the viral protein VPg. A single open reading frame encodes all of the viral proteins: P1 encodes the structural proteins (VP1, VP2 and VP3 and the putative VP4) and the P2 and P3 regions encode the non-structural proteins associated with replication (Fig. 1
). Finally, there is a short 3' UTR terminating in a poly(A) tract.
|
![]() |
Genotype history and classification |
---|
The founding works on HAV genetic variability made use of discrete, selected partial HAV genomic regions, such as the C terminus of VP3 (Jansen et al., 1990), the N terminus of VP1 (Robertson et al., 1991
) or the putative VP12A junction region (Fig. 1
) (Jansen et al., 1990
; Robertson et al., 1992
). Since HAV and poliovirus share many genomic features, the different HAV strains were grouped by comparing the VP12A junction and using the method of Rico-Hesse and co-workers, a criterion used at the time for the genetic classification of poliovirus strains (Rico-Hesse et al., 1987
). In 1992, using this approach, genetic analysis of 152 strains of HAV recovered around the world resulted in the designation of seven genotypes of HAV (IVII) (Fig. 2
A). A genotype is therefore defined as a group of viruses with >85 % nucleotide sequence identity (Robertson et al., 1992
). Viruses from four of the genotypes (I, II, III and VII) were recovered from HAV human cases, whereas viruses from the other three genotypes (IV, V and VI) were isolated only from unique simian species developing a hepatitis A-like illness during captivity (Nainan et al., 1991
; Tsarev et al., 1991
; Robertson et al., 1992
). Genotypes I and III were subdivided further into two distinct groups (subgenotypes), which differed in sequence in no more than 7·5 % of base positions.
|
To gain insight into the genetic variability of HAV and as an alternative to comparing the percentage of identity within short (168 nucleotides) selected regions of the genome, phylogenetic studies were carried out using full-length VP1 sequences (900 nucleotides) (Costa-Mattioli et al., 2002). Why was the full-length VP1 region chosen? Firstly, VP1 is the major surface-accessible protein in the mature picornavirus particle (Hughes et al., 1984
; Hogle et al., 1985
; Mateu et al., 1995
). HAV escape mutants generated under mAb selection have shown that a number of amino acids within the VP1 protein contribute to the major immunodominant site of HAV (Stapleton et al., 1985
; Stapleton & Lemon, 1987
; Ping et al., 1988
; Ping & Lemon, 1992
). Secondly, molecular evolution studies have recently shown beyond doubt that sequence determination of the full-length VP1 was required to properly characterize human and simian strains of picornaviruses (Oberste et al., 1998
, 1999
, 2001
; Brown et al., 1999
; Haydon et al., 2001
; McMinn et al., 2001
; Norder et al., 2001
). Thirdly, since the VP1 sequence of enterovirus correlates to some extent with serotype, the VP1 sequence can be used as a molecular surrogate for antigenic typing (Oberste et al., 1999
, 2000
, 2001
, 2002
; Brown et al., 2000
; Caro et al., 2001
; Casas et al., 2001
; Costa-Mattioli et al., 2002
; Norder et al., 2001
).
Phylogenetic analysis of complete VP1 sequences of 86 HAV strains isolated worldwide unexpectedly revealed the presence of five distinct genetic groups (Fig. 2B), all of them supported by high bootstrap values (Costa-Mattioli et al., 2002
). The only sequences not included in these studies were the one of strain JM-55 (genotype VI) and those representing genotype IIIB, because none of them were available in a public sequence database at that time. Based on these studies, a novel classification of HAV genotypes was proposed (Costa-Mattioli et al., 2002
). Strikingly, the least observed variation was found between the previously established genotypes II and VII (Costa-Mattioli et al., 2002
). These findings suggest that the previously defined genotypes II and VII (Robertson et al., 1992
) may be one or two subgenotypes of the same type. A simple hypothesis is that a recombination event has taken place among strains of these two genotypes. To test this, phylogenetic analysis of the three major capsid proteins (VP1, VP2 and VP3) and the VP12A junction were carried out. Phylogenetic comparison of VP1 full-length protein (Fig. 2B
) and the VP12A region (Fig. 2A
) (Robertson et al., 1992
), with the phylogeny based on the entire VP2 and VP3 sequences (Fig. 2C, D
) (Costa-Mattioli et al., 2003
), revealed that the phylogenetic trees were non-congruent, consistent with the notion that some of these strains might have arisen by recombination.
To determine the basis of this discrepancy, recombination analysis using RIP (recombination identification program) was carried out (Fig. 3A) (Costa-Mattioli et al., 2003
). Analyses of these data sets showed that a recombination event occurred between the putative parental strains MBB (genotype IB) and SLF-88 (genotype VII) to generate the mosaic 9F94 strain (Fig. 3
) (Costa-Mattioli et al., 2003
). Indeed, a further characterization of the putative breakpoint site using the LARD method (Holmes et al., 1999) clearly shows the point of recombination on position 1461 of the sequences analysed, corresponding to position 51 of the VP1 protein (Costa-Mattioli et al., 2003
).
|
![]() |
Distribution of HAV genotypes |
---|
It was found that HAV strains from Central and South America all belonged to subgenotype IA, suggesting that there is a circulating endemic population in these countries (Arauz-Ruiz et al., 2001; Costa-Mattioli et al., 2001a
; Diaz et al., 2001
; Mbayed et al., 2002
). A recent report, however, has revealed the concomitant circulation of subgenotypes IA and IB in Brazil (de Paula et al., 2002
, 2003
). In addition, IB subgenotype HAV strains were isolated from shellfish imported from Peru (Sanchez et al., 2002
).
Genotype IB contained strains from Jordan, North Africa, Australia, Europe and Japan (Robertson et al., 1992). Co-circulation of subgenotype IA and IB was reported in South Africa (Taylor, 1997
).
In Europe, a more complex pattern has been observed because HAV isolates derive from multiple genotypes, probably representing viruses from other regions (Robertson et al., 1992; Apaire-Marchais et al., 1995
; Bruisten et al., 2001
; Costa-Mattioli et al., 2001b
, 2002
; Pina et al., 2001
; Sanchez et al., 2002
). For instance, in western Europe, HAV isolates were derived from multiple genotypes (Apaire-Marchais et al., 1995
; Costa-Mattioli et al., 2001b
, 2002
; Pina et al., 2001
; Sanchez et al., 2002
; Chironna et al., 2003
).
Most of the remaining human HAV strains are segregated in genotype III, which has two subgenotypes (IIIA and IIIB) (Robertson et al., 1992). The prototype virus strain of the genotype IIIA, PA21, a subgenotype linked previously to intravenous drug users in Sweden during the 1980s (Robertson et al., 1992
) and in Norway at the end of the 1990s (Stene-Johansen et al., 1998
), was originally isolated from captured Panamanian owl monkeys (Brown et al., 1989
). Strains closely related to this genotype have been collected from humans with HAV in India, Sri Lanka, Nepal, Malaysia and USA (Jansen et al., 1990
; Robertson et al., 1991
; Khanna et al., 1992
). Recently, genetic analysis of HAV strains isolated from environmental samples, such as a shellfish-associated outbreak in France, Spanish sewage samples and mussels imported to Italy, revealed for the first time the presence of strains closely related to genotype IIIA in those countries (Costa-Mattioli et al., 2001b
; Pina et al., 2001
; Chironna et al., 2003
). Therefore, the molecular epidemiology of HAV infection in southern European countries (Italy, Spain and France) seems to confirm the presence of different HAV strain variants in western Europe and the Mediterranean. In general, genetic analysis of strains can provide valuable information with regard to the source of the virus in both sporadic and epidemic infection (De Serres et al., 1999
; Costa-Mattioli et al., 2001b
; Pina et al., 2001
; Chironna et al., 2003
). Recently, Tallo et al. (2003)
reported that, although genotype IA was the predominant one in Estonia during the past years, the last HAV outbreak was associated to a genotype IIIA HAV strain. In fact, the replacement of one genotype with another one may explain, at least in part, the shift in HAV epidemiology from a disease in children to an infection in young adults (Cianciara, 2000
; Tanaka, 2000
). Taken together, these data suggest that genotype IIIA is becoming significantly more prevalent among the HAV-infected population than previously appreciated.
Early studies on HAV isolates from cell culture have shown little (if any) genetic variation between the different strains, most likely associated to cell culture cross-contamination problems. However, more recent PCR studies based on strains isolated from clinical specimens (stools, liver suspension and serum) have shown more genetic heterogeneity. In regions of the world such as the USA, Japan and China, HAV-related isolates tend to cluster, suggesting an endemic spread. A high degree of genetic conservation was shown during the infection period of an individual (Robertson et al., 1992, 2000
) or even among different isolates with a common source of infection (Grinde et al., 1997
; Chudy et al., 1999
; De Serres et al., 1999
; Arauz-Ruiz et al., 2001
; Diaz et al., 2001
; Tallo et al., 2003
). In contrast, a higher degree of heterogeneity than reported previously has been found in strains isolated in South America (Costa-Mattioli et al., 2001a
, 2002
; de Paula et al., 2002
; Mbayed et al., 2002
). Surprisingly, the N terminus of the VP1 region from strains isolated in South America was more variable than the VP12A junction region (Costa-Mattioli et al., 2001a
; Mbayed et al., 2002
). Moreover, these strains did not cluster according to geographic origin, as was reported for isolates from Europe (Costa-Mattioli et al., 2002
) and from other regions of the world (Robertson et al., 1991
, 1992
, 2000
; Robertson & Naiman, 1997
; Taylor, 1997
). Recent studies suggest a changing epidemiologic pattern in HAV infection throughout South America, which may result in more clinical cases in teenagers and adults and a greater potential for new outbreaks (Tapia-Conyer et al., 1999
; Tanaka, 2000
). Whether this changing pattern is related to a higher genetic variability of HAV in that particular geographic region than expected previously to changes in hygienic conditions or to a combination of these and other factors remains to be established.
Genotypes II and VII were also described using the traditional approach (Robertson et al., 1992) and each has only a single strain. Genotype VII contains a strain isolated in Sierra Leona in 1988 (SLF88), whereas genotype II is represented by a strain isolated in France in 1979 (CF-53). Although the complete sequence of strain SLF88 was published recently (Ching et al., 2002
), only 168 nucleotides corresponding to strain CF-53 are known.
The remaining three genotypes are also represented by a single unique strain recovered from a species of Old World monkey (Robertson, 2001). Two of these were recovered at a primate facility in the former USSR, one from a cynomolgus macaque (Macaca fasicularis) imported from Indonesia (genotype VI, strain JM55) (Robertson et al., 1992
) and the other from an African green monkey (Cercopithecus aethiops) imported from Kenya (genotype V, strain AGM27) (Tsarev et al., 1991
). The other simian strain was recovered in Atlanta, GA, USA, from a cynomolgus macaque imported from the Philippines (genotype IV, strain Cy145) (Nainan et al., 1991
). These simian strains tend to differ genetically as much between themselves as they do from human viruses. Strains AGM27 and JM55 appear to be more closely related to each other than to the Cy145 strain even though they were recovered from different species of primate.
In summary, molecular epidemiologic studies tend to suggest that the degree of genetic heterogeneity among HAV isolates from different areas of the world is higher than expected.
![]() |
HAV evolution |
---|
![]() |
Mutation rate and mode of evolution |
---|
The first study attempting to estimate the number of synonymous mutations per synonymous site (Ks) of HAV was reported recently by Sanchez et al. (2003). Ks values from HAV strains isolated from a clam-associated outbreak were 7·5 times lower in the VP12A region than the Ks values for GenBank sequences representing geographically and temporally divergent HAV strains. The estimated Ks values varied from 0·038 for VP0 to 0·29 for VP1 (Sanchez et al., 2003
) and the Ks value of the P1 region was reported to be close to that obtained for foot-and-mouth disease virus (FMDV).
Since Ks values were not calculated based on monophyletic clusters that spanned a period of at least 10 years, further studies on HAV rates will be required to confirm these findings.
The mode of HAV evolution was recently studied by two groups. Genetic studies using full-length VP1 and capsid sequences have shown the presence of different patterns in the intragenic distributions of synonymous substitutions in the VP1 protein, suggesting that synonymous divergence could be random in the VP1 gene (Costa-Mattioli et al., 2002, 2003
). Nevertheless, the distribution of non-synonymous substitutions along the VP1 protein shows a completely different situation, with extremely low rates of substitutions compared to those of synonymous substitutions. Thus, the pattern of divergence observed for HAV VP1 is probably due to selective forces that do not allow amino acid replacements, despite the relative high rates of synonymous substitutions observed all over the gene. Consequently, negative selection appears to be the main force shaping the pattern of non-synonymous substitutions, selecting against most replacements in all protein regions and resulting in a well-conserved protein. These data were confirmed in an extended comparison of the whole HAV capsid region (Sanchez et al., 2003
). This is in contrast with the situation found in multiple serotype viruses, such as the haemagglutinin gene of influenza virus (Ina & Gojobori, 1994
), the complete capsid region of serotypes A and C of FMDV (Haydon et al., 2001
) and the VP3 region of human immunodeficiency virus (Seibert et al., 1995
), which are all subjected to positive selection.
Thus, the mode of evolution of HAV appears, at least in part, to explain the presence of only one known serological group of HAV.
![]() |
Recombination |
---|
Genetic recombination was first described in poliovirus (Hirst, 1962; Ledinko, 1963
). Later, a number of recombination events was reported between strains that are genetically related (intratypic recombination) and between those that are more distantly related (intertypic recombination).
It is generally accepted that the most biologically relevant mechanism of recombination, in which RNA molecules are joined by an actively copying RNA polymerase that switches from one template to another during negative-strand synthesis is copy-choice (Kirkegaard & Baltimore, 1986; Jarvis & Kirkegaard, 1992
). Regardless, however, recombination has also been observed with non-replicating genomes (Gmyl et al., 1999
) and, recently, Pierangeli et al. (1999)
produced experimental evidence supporting a primer alignment-and-extension model in which prematurely terminated RNA molecules hybridize to homologous sequences in the opposite strand of a replication complex and serve as primers that are subsequently extended.
Most of the recombinant strains described previously were isolated from experimental infection in cell culture under an artificial selective pressure. Kew & Nottay (1984) first reported the isolation of a naturally occurring recombinant poliovirus that contained sequences derived from all three serotypes of poliovirus vaccine strains as a result of two crossovers. Recombination among vaccine and wild-type polioviruses has been reported as a natural means of evolution of poliovirus (Guillot et al., 2000
). This has also been observed in enterovirus (Santti et al., 1999
). In the case of HAV, genetic exchange among strains had been observed in cell culture (Lemon et al., 1991
; Beard et al., 2001
; Gauss-Muller & Kusov, 2002
) but for many years it was supposed not to occur in nature. This view was subsequently challenged by the report of a case of dual infection of a young childcare provider (AUX-23) with HAV strains belonging to different subgenotypes (de Paula et al., 2003
). It is noteworthy that AUX-23 was hired at a childcare centre in which HAV IA and IB were circulating. These particular conditions may have facilitated the double infection. However, the incidence of common HAV mixed infection in single individuals is unknown (C. Niel, Department of Virology, Oswaldo Cruz Institute, Rio de Janeiro, Brazil, personal communication). Indeed, the first HAV recombinant isolated from an infected patient was reported recently (Fig. 3
) (Costa-Mattioli et al., 2003
). The recombinant strain 9F94 comes from a little girl who was hospitalized in France after a 3 month holiday in Morocco. Accordingly, the putative parental strains SLF88 (genotype VII) and MBB (genotype IB) were also originally isolated in North Africa, a region of high endemicity for HAV infection and one in which multiple genotypes co-circulate (Melnick, 1995
). Recombination requires double infection of a single cell. Two conditions were therefore necessary for this to occur: co-circulation of different genotypes in a given geographic area and in a short period of time and infection of a susceptible subject with at least two sources of infection.
Evidence of recombination in polio- and enteroviruses was confined to areas far removed from the capsid region (Kew & Nottay, 1984; Lipskaya et al., 1991
; Guillot et al., 2000
; Cuervo et al., 2001
; Kew et al., 2002
). Recently, however, poliovirus (Liu et al., 2000
; Martin et al., 2002
) and FMDV recombinants in the capsid region (Tosh et al., 2002
) have been reported. Studies using HAV capsid sequences revealed intertypic recombination (genotypes IB and VII) in the VP1 capsid protein of a human HAV strain 9F94 (Fig. 3A, B
) (Costa-Mattioli et al., 2003
). These findings indicate that capsid recombination may play a significant role in shaping the genetic diversity of HAV and, as such, can have important implications for its evolution, biology and control. HAV recombination may serve two opposite purposes: exploration of new combinations of genomic regions from different origins or rescuing of viable genomes from debilitated parental genomes (Lai, 1992
; Domingo & Holland, 1997
; Domingo et al., 1997
; Worobey & Holmes, 1999
). Evidence for recombination is most easily demonstrated when the genomic sequences of both parental viruses are known. The frequency and possible implications of HAV capsid recombination events for the generation of pathogenic HAV strains are not clear at present.
![]() |
Antigenic divergence |
---|
Cell culture studies revealed that mutants selected by passage in the presence of a mAb became resistant to neutralization by that antibody (Stapleton & Lemon, 1987; Ping et al., 1988
; Nainan et al., 1992
). Neutralization escape mutations for the human HAV strain HM-175 were identified at Asp70 and Gln74 of the VP3 protein and Ser102, Val171 and Lys221 of the VP1 protein (Ping et al., 1988
; Ping & Lemon, 1992
); however, those for strain HAS15 were identified at Pro65, Asp70 and Ser71 of the VP3 protein and Asn104, Lys105 and Gln232 of the VP1 protein (Nainan et al., 1992
). The deleted region found in strain Uru-3 contains three amino acids (Ser102, Asn104 and Asn105) reported to be able to induce an escape response in neutralization experiments (Costa-Mattioli et al., 2002
). Moreover, these residues align with recognized immunogenic sites in human rhinovirus type 14 (HRV-14) (Rossmann et al., 1985
) and poliovirus type 3 (PV-3) (Fig. 4
) (Hogle et al., 1985
; Minor et al., 1986
). This suggests that these residues are part of an immunogenic site that is analogous to neutralization immunogenic sites found in other picornaviruses (HRV-14 and PV-3). Therefore, it is possible that the deletion found in strain Uru-3 may alter the antigenic structure of the virus and suggests that this strain may be the first antigenic variant of HAV found in humans (Costa-Mattioli et al., 2002
).
|
Since HAV strains isolated from South America were reported to contain a highly genetic (Costa-Mattioli et al., 2001a, 2002
; de Paula et al., 2002
, 2003
; Mbayed et al., 2002
) and antigenic (Costa-Mattioli et al., 2002
; Sanchez et al., 2003
) variability, it is possible to speculate that a new serological type could emerge from this geographic region.
![]() |
Conclusions |
---|
![]() |
ACKNOWLEDGEMENTS |
---|
![]() |
REFERENCES |
---|
Apaire-Marchais, V., Robertson, B. H., Aubineau-Ferre, V., Le Roux, M. G., Leveque, F., Schwartzbrod, L. & Billaudel, S. (1995). Direct sequencing of hepatitis A virus strains isolated during an epidemic in France. Appl Environ Microbiol 61, 39773980.[Abstract]
Arauz-Ruiz, P., Sundqvist, L., Garcia, Z., Taylor, L., Visona, K., Norder, H. & Magnius, L. O. (2001). Presumed common source outbreaks of hepatitis A in an endemic area confirmed by limited sequencing within the VP1 region. J Med Virol 65, 449456.[CrossRef][Medline]
Baroudy, B. M., Ticehurst, J. R., Miele, T. A., Maizel, J. V., Jr, Purcell, R. H. & Feinstone, S. M. (1985). Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase. Proc Natl Acad Sci U S A 82, 21432147.[Abstract]
Beard, M. R., Cohen, L., Lemon, S. M. & Martin, A. (2001). Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction. J Virol 75, 14141426.
Brown, E. A., Jansen, R. W. & Lemon, S. M. (1989). Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV. J Virol 63, 49324937.[Medline]
Brown, B. A., Oberste, M. S., Alexander, J. P., Jr, Kennett, M. L. & Pallansch, M. A. (1999). Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 73, 99699975; erratum 74, 12003.[CrossRef]
Brown, B. A., Kilpatrick, D. R., Oberste, M. S. & Pallansch, M. A. (2000). Serotype-specific identification of enterovirus 71 by PCR. J Clin Virol 16, 107112; erratum 24, 211.
Bruisten, S. M., van Steenbergen, J. E., Pijl, A. S., Niesters, H. G., van Doornum, G. J. & Coutinho, R. A. (2001). Molecular epidemiology of hepatitis A virus in Amsterdam, the Netherlands. J Med Virol 63, 8895.[CrossRef][Medline]
Caro, V., Guillot, S., Delpeyroux, F. & Crainic, R. (2001). Molecular strategy for serotyping of human enteroviruses. J Gen Virol 82, 7991.
Casas, I., Palacios, G. F., Trallero, G., Cisterna, D., Freire, M. C. & Tenorio, A. (2001). Molecular characterization of human enteroviruses in clinical samples: comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products. J Med Virol 65, 138148.[CrossRef][Medline]
CDC (1999). Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 48, 137.[Medline]
Ching, K. Z., Nakano, T., Chapman, L. E., Demby, A. & Robertson, B. H. (2002). Genetic characterization of wild-type genotype VII hepatitis A virus. J Gen Virol 83, 5360.
Chironna, M., Grottola, A., Lanave, C., Villa, E., Barbuti, S. & Quarto, M. (2003). Genetic analysis of HAV strains recovered from patients with acute hepatitis from Southern Italy. J Med Virol 70, 343349.[CrossRef][Medline]
Chudy, M., Budek, I., Keller-Stanislawski, B., McCaustland, K. A., Neidhold, S., Robertson, B. H., Nubling, C. M., Seitz, R. & Lower, J. (1999). A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool. J Med Virol 57, 9199.[CrossRef][Medline]
Cianciara, J. (2000). Hepatitis A shifting epidemiology in Poland and Eastern Europe. Vaccine 18 (Suppl. 1), S68S70.[CrossRef][Medline]
Cohen, J. I., Rosenblum, B., Ticehurst, J. R., Daemer, R. J., Feinstone, S. M. & Purcell, R. H. (1987a). Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A 84, 24972501.[Abstract]
Cohen, J. I., Ticehurst, J. R., Feinstone, S. M., Rosenblum, B. & Purcell, R. H. (1987b). Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol 61, 30353039.[Medline]
Costa-Mattioli, M., Ferré, V., Monpoeho, S., Garcia, L., Colina, R., Billaudel, S., Vega, I., Perez-Bercoff, R. & Cristina, J. (2001a). Genetic variability of hepatitis A virus in South America reveals heterogeneity and co-circulation during epidemic outbreaks. J Gen Virol 82, 26472652.
Costa-Mattioli, M., Monpoeho, S., Schvoerer, C., Besse, B., Aleman, M. H., Billaudel, S., Cristina, J. & Ferré, V. (2001b). Genetic analysis of hepatitis A virus outbreak in France confirms the co-circulation of subgenotypes Ia, Ib and reveals a new genetic lineage. J Med Virol 65, 233240.[CrossRef][Medline]
Costa-Mattioli, M., Cristina, J., Romero, H. & 12 other authors (2002). Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J Virol 76, 95169525.
Costa-Mattioli, M., Ferré, V., Casane, D. & 7 other authors (2003). Evidence of recombination in natural populations of hepatitis A virus. Virology 311, 5159.[CrossRef][Medline]
Crevat, D., Crance, J. M., Chevrinais, A. M., Passagot, J., Biziagos, E., Somme, G. & Deloince, R. (1990). Monoclonal antibodies against an immunodominant and neutralizing epitope on hepatitis A virus antigen. Arch Virol 113, 9598.[Medline]
Cuervo, N. S., Guillot, S., Romanenkova, N., Combiescu, M., Aubert-Combiescu, A., Seghier, M., Caro, V., Crainic, R. & Delpeyroux, F. (2001). Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees. J Virol 75, 57405751.
Daemer, R. J., Feinstone, S. M., Gust, I. D. & Purcell, R. H. (1981). Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect Immun 32, 388393.[Medline]
de Paula, V. S., Baptista, M. L., Lampe, E., Niel, C. & Gaspar, A. M. (2002). Characterization of hepatitis A virus isolates from subgenotypes IA and IB in Rio de Janeiro, Brazil. J Med Virol 66, 2227.[CrossRef][Medline]
de Paula, V. S., Saback, F. L., Gaspar, A. M. & Niel, C. (2003). Mixed infection of a child care provider with hepatitis A virus isolates from subgenotypes IA and IB revealed by heteroduplex mobility assay. J Virol Methods 107, 223228.[CrossRef][Medline]
De Serres, G., Cromeans, T. L., Levesque, B. & 8 other authors (1999). Molecular confirmation of hepatitis A virus from well water: epidemiology and public health implications. J Infect Dis 179, 3743.[CrossRef][Medline]
Diaz, B. I., Sariol, C. A., Normann, A., Rodriguez, L. & Flehmig, B. (2001). Genetic relatedness of Cuban HAV wild-type isolates. J Med Virol 64, 96103.[CrossRef][Medline]
Divizia, M., Ruggeri, F., Hentschel, J., Flehmig, B., Pana, A. & Perez-Bercoff, R. (1986). Preliminary characterization of a fast-growing strain of human hepatitis A virus. Microbiologica 9, 269278.[Medline]
Domingo, E. & Holland, J. J. (1997). RNA virus mutations and fitness for survival. Annu Rev Microbiol 51, 151178.[CrossRef][Medline]
Domingo, E., Menendez-Arias, L. & Holland, J. J. (1997). RNA virus fitness. Rev Med Virol 7, 8796.[CrossRef][Medline]
Flehmig, B. (1980). Hepatitis A-virus in cell culture. I. Propagation of different hepatitis A-virus isolates in a fetal rhesus monkey kidney cell line (FrhK-4). Med Microbiol Immunol (Berl) 168, 239248.[Medline]
Frosner, G. G., Deinhardt, F., Scheid, R., Gauss-Muller, V., Holmes, N., Messelberger, V., Siegl, G. & Alexander, J. J. (1979). Propagation of human hepatitis A virus in a hepatoma cell line. Infection 7, 303305.[Medline]
Gaspar, A. M., Vitral, C. L., Yoshida, C. F. & Schatzmayr, H. G. (1992). Primary isolation of a Brazilian strain of hepatitis A virus (HAF-203) and growth in a primate cell line (FRhK-4). Braz J Med Biol Res 25, 697705.[Medline]
Gauss-Muller, V. & Kusov, Y. Y. (2002). Replication of a hepatitis A virus replicon detected by genetic recombination in vivo. J Gen Virol 83, 21832192.
Germinario, C., Lopalco, P. L., Chirona, M., Da Villa, G. & Chicanna, M. (2000). From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience. Vaccine 18 (Suppl. 1), S83S85.[CrossRef][Medline]
Gmyl, A. P., Belousov, E. V., Maslova, S. V., Khitrina, E. V., Chetverin, A. B. & Agol, V. I. (1999). Nonreplicative RNA recombination in poliovirus. J Virol 73, 89588965.
Grinde, B., Stene-Johansen, K., Sharma, B., Hoel, T., Jensenius, M. & Skaug, K. (1997). Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers infection by needle sharing? J Med Virol 53, 6975.[CrossRef][Medline]
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F. & Crainic, R. (2000). Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 74, 84348443.
Gust, I. D., Lehmann, N. I., Crowe, S., McCrorie, M., Locarnini, S. A. & Lucas, C. R. (1985). The origin of the HM175 strain of hepatitis A virus. J Infect Dis 151, 365367.[Medline]
Hadler, S. C., Webster, H. M., Erben, J. J., Swanson, J. E. & Maynard, J. E. (1980). Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med 302, 12221227.[Abstract]
Haydon, D. T., Bastos, A. D., Knowles, N. J. & Samuel, A. R. (2001). Evidence for positive selection in foot-and-mouth disease virus capsid genes from field isolates. Genetics 157, 715.
Hirst, G. K. (1962). Genetic recombination with Newcastle virus, polioviruses and influenza. Cold Spring Harbor Symp Quant Biol 27, 303308.
Hogle, J. M., Chow, M. & Filman, D. J. (1985). Three-dimensional structure of poliovirus at 2·9 Å resolution. Science 229, 13581365.[Medline]
Hollinger, F. B. & Emerson, S. U. (2001). Hepatitis A virus. In Fields Virology, 4th edn, pp. 799840. Edited by D. M. Knipe & P. M. Howley. New York: Lippincott Williams & Wilkins.
Hughes, J. V., Stanton, L. W., Tomassini, J. E., Long, W. J. & Scolnick, E. M. (1984). Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site. J Virol 52, 465473.[Medline]
Ina, Y. & Gojobori, T. (1994). Statistical analysis of nucleotide sequences of the hemagglutinin gene of human influenza A viruses. Proc Natl Acad Sci U S A 91, 83888392.[Abstract]
Jansen, R. W., Siegl, G. & Lemon, S. M. (1990). Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method. Proc Natl Acad Sci U S A 87, 28672871.[Abstract]
Jarvis, T. C. & Kirkegaard, K. (1992). Poliovirus RNA recombination: mechanistic studies in the absence of selection. EMBO J 11, 31353145.[Abstract]
Kew, O. M. & Nottay, B. K. (1984). Evolution of the oral polio-vaccine strains in humans occurs by both mutation and intra-molecular recombination. In Modern Approaches to Vaccines: Molecular and Chemical Basis of Virus Virulence and Immunogenicity, pp. 357362. Edited by E. D. Lerner. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
Kew, O., Morris-Glasgow, V., Landaverde, M. & 21 other authors (2002). Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296, 356359.
Khanna, B., Spelbring, J. E., Innis, B. L. & Robertson, B. H. (1992). Characterization of a genetic variant of human hepatitis A virus. J Med Virol 36, 118124.[Medline]
Kirkegaard, K. & Baltimore, D. (1986). The mechanism of RNA recombination in poliovirus. Cell 47, 433443.[Medline]
Lai, M. M. (1992). RNA recombination in animal and plant viruses. Microbiol Rev 56, 6179.[Medline]
Ledinko, N. (1963). Genetic recombination with poliovirus type 1: studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain. Virology 20, 107119.[CrossRef]
Lemon, S. M., Chao, S. F., Jansen, R. W., Binn, L. N. & LeDuc, J. W. (1987). Genomic heterogeneity among human and nonhuman strains of hepatitis A virus. J Virol 61, 735742.[Medline]
Lemon, S. M., Murphy, P. C., Shields, P. A., Ping, L. H., Feinstone, S. M., Cromeans, T. & Jansen, R. W. (1991). Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination. J Virol 65, 20562065.[Medline]
Lenfant, C. (1994). From the National Institutes of Health. JAMA 272, 842.[CrossRef][Medline]
Linemeyer, D. L., Menke, J. G., Martin-Gallardo, A., Hughes, J. V., Young, A. & Mitra, S. W. (1985). Molecular cloning and partial sequencing of hepatitis A viral cDNA. J Virol 54, 247255.[Medline]
Lipskaya, G. Y., Muzychenko, A. R., Kutitova, O. K., Maslova, S. V., Equestre, M., Drozdov, S. G., Bercoff, R. P. & Agol, V. I. (1991). Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases. J Med Virol 35, 290296.[Medline]
Liu, H. M., Zheng, D. P., Zhang, L. B., Oberste, M. S., Pallansch, M. A. & Kew, O. M. (2000). Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74, 1115311161.
Martin, J., Samoilovich, E., Dunn, G. & 7 other authors (2002). Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J Virol 76, 1092110928.
Mateu, M. G., Camarero, J. A., Giralt, E., Andreu, D. & Domingo, E. (1995). Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206, 298306.[CrossRef][Medline]
Matthews, R. E. (1979). The classification and nomenclature of viruses. Intervirology 11, 133135.[Medline]
Matthews, R. E. (1982). Classification and nomeclature of viruses. Intervirology 17, 1199.[Medline]
Mbayed, V. A., Sookoian, S., Alfonso, V. & Campos, R. H. (2002). Genetic characterization of hepatitis A virus isolates from Buenos Aires, Argentina. J Med Virol 68, 168174.[CrossRef][Medline]
McMinn, P., Lindsay, K., Perera, D., Chan, H. M., Chan, K. P. & Cardosa, M. J. (2001). Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 75, 77327738.
Mele, A., Rosmini, F., Zampieri, A. & Gill, O. N. (1986). Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. Eur J Epidemiol 2, 300304.[Medline]
Melnick, J. L. (1992). Properties and classification of hepatitis A virus. Vaccine 10 (Suppl. 1), S24S26.[CrossRef][Medline]
Melnick, J. L. (1995). History and epidemiology of hepatitis A virus. J Infect Dis 171 (Suppl. 1), S2S8.[Medline]
Minor, P. D., John, A., Ferguson, M. & Icenogle, J. P. (1986). Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol 67, 693706.[Abstract]
Montano, A. (2002). Viral hepatitis in children: epidemiology and prophylaxis. Inst Hyg Mono Ser 2, 102106 (in Spanish).
Nagy, P. D. & Simon, A. E. (1997). New insights into the mechanisms of RNA recombination. Virology 235, 19.[CrossRef][Medline]
Nainan, O. V., Margolis, H. S., Robertson, B. H., Balayan, M. & Brinton, M. A. (1991). Sequence analysis of a new hepatitis A virus naturally infecting cynomolgus macaques (Macaca fascicularis). J Gen Virol 72, 16851689.[Abstract]
Nainan, O. V., Brinton, M. A. & Margolis, H. S. (1992). Identification of amino acids located in the antibody binding sites of human hepatitis A virus. Virology 191, 984987.[Medline]
Najarian, R., Caput, D., Gee, W., Potter, S. J., Renard, A., Merryweather, J., Van Nest, G. & Dina, D. (1985). Primary structure and gene organization of human hepatitis A virus. Proc Natl Acad Sci U S A 82, 26272631.[Abstract]
Norder, H., Bjerregaard, L. & Magnius, L. O. (2001). Homotypic echoviruses share aminoterminal VP1 sequence homology applicable for typing. J Med Virol 63, 3544.[CrossRef][Medline]
Oberste, M. S., Maher, K. & Pallansch, M. A. (1998). Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses. Virus Res 56, 217223.[CrossRef][Medline]
Oberste, M. S., Maher, K., Kilpatrick, D. R. & Pallansch, M. A. (1999). Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 73, 19411948.
Oberste, M. S., Maher, K., Flemister, M. R., Marchetti, G., Kilpatrick, D. R. & Pallansch, M. A. (2000). Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol 38, 11701174.
Oberste, M., Schnurr, D., Maher, K., al-Busaidy, S. & Pallansch, M. (2001). Molecular identification of new picornaviruses and characterization of a proposed enterovirus 73 serotype. J Gen Virol 82, 409416.
Oberste, M. S., Maher, K. & Pallansch, M. A. (2002). Molecular phylogeny and proposed classification of the simian picornaviruses. J Virol 76, 12441251.
Ovchinnikov Iu, A., Sverdlov, E. D., Tsarev, S. A., Arsenian, S. G. & Rokhlina, T. O. (1985). Sequence of 3372 RNA nucleotide links in the hepatitis A virus coding for capsid VP4-VP1 and nonstructural proteins. Dokl Akad Nauk SSSR 285, 10141108 (in Russian).[Medline]
Paul, A. V., Tada, H., von der Helm, K., Wissel, T., Kiehn, R., Wimmer, E. & Deinhardt, F. (1987). The entire nucleotide sequence of the genome of human hepatitis A virus (isolate MBB). Virus Res 8, 153171.[CrossRef][Medline]
Pierangeli, A., Bucci, M., Forzan, M., Pagnotti, P., Equestre, M. & Perez Bercoff, R. (1999). Primer alignment-and-extension: a novel mechanism of viral RNA recombination responsible for the rescue of inactivated poliovirus cDNA clones. J Gen Virol 80, 18891897.
Pina, S., Buti, M., Jardi, R., Clemente-Casares, P., Jofre, J. & Girones, R. (2001). Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis. J Gen Virol 82, 29552963.
Ping, L. H. & Lemon, S. M. (1992). Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol 66, 22082216.[Abstract]
Ping, L. H., Jansen, R. W., Stapleton, J. T., Cohen, J. I. & Lemon, S. M. (1988). Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc Natl Acad Sci U S A 85, 82818285.[Abstract]
Posada, D. & Crandall, K. A. (2001). Evaluation of methods for detecting recombination from DNA sequences: computer simulations. Proc Natl Acad Sci U S A 98, 1375713762.
Rico-Hesse, R., Pallansch, M. A., Nottay, B. K. & Kew, O. M. (1987). Geographic distribution of wild poliovirus type 1 genotypes. Virology 160, 311322.[Medline]
Robertson, B. H. (2001). Viral hepatitis and primates: historical and molecular analysis of human and nonhuman primate hepatitis A, B, and the GB-related viruses. J Viral Hepat 8, 233242.[CrossRef][Medline]
Robertson, B. & Naiman, O. (1997). Genetic and antigenic variants of hepatitis A virus. In Viral Hepatitis and Liver Disease, pp. 1418. Edited by G. Verme. Torino: Edizioni Minerva Medica.
Robertson, B. H., Khanna, B., Nainan, O. V. & Margolis, H. S. (1991). Epidemiologic patterns of wild-type hepatitis A virus determined by genetic variation. J Infect Dis 163, 286292.[Medline]
Robertson, B. H., Jansen, R. W., Khanna, B. & 10 other authors (1992). Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 73, 13651377.[Abstract]
Robertson, B. H., Averhoff, F., Cromeans, T. L. & 8 other authors (2000). Genetic relatedness of hepatitis A virus isolates during a community-wide outbreak. J Med Virol 62, 144150.[CrossRef][Medline]
Ross, B. C. & Anderson, D. A. (1991). Characterization of hepatitis A virus capsid proteins with antisera raised to recombinant antigens. J Virol Methods 32, 213220.[CrossRef][Medline]
Rossmann, M. G., Arnold, E., Erickson, J. W. & 15 other authors (1985). Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317, 145153.[Medline]
Sanchez, G., Pinto, R. M., Vanaclocha, H. & Bosch, A. (2002). Molecular characterization of hepatitis A virus isolates from a transcontinental shellfish-borne outbreak. J Clin Microbiol 40, 41484155.
Sanchez, G., Bosch, A. & Pinto, R. M. (2003). Genome variability and capsid structural constraints of hepatitis A virus. J Virol 77, 452459.[CrossRef][Medline]
Santti, J., Hyypia, T., Kinnunen, L. & Salminen, M. (1999). Evidence of recombination among enteroviruses. J Virol 73, 87418749.
Schierup, M. H. & Hein, J. (2000). Consequences of recombination on traditional phylogenetic analysis. Genetics 156, 879891.
Seibert, S. A., Howell, C. Y., Hughes, M. K. & Hughes, A. L. (1995). Natural selection on the gag, pol, and env genes of human immunodeficiency virus 1 (HIV-1). Mol Biol Evol 12, 803813.[Abstract]
Stapleton, J. T. & Lemon, S. M. (1987). Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J Virol 61, 491498.[Medline]
Stapleton, J. T., Jansen, R. & Lemon, S. M. (1985). Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin. Gastroenterology 89, 637642.[Medline]
Stene-Johansen, K., Skaug, K., Blystad, H. & Grinde, B. (1998). A unique hepatitis A virus strain caused an epidemic in Norway associated with intravenous drug abuse. The Hepatitis A Study Group. Scand J Infect Dis 30, 3538.[CrossRef][Medline]
Tallo, T., Norder, H., Tefanova, V. & 9 other authors (2003). Sequential changes in hepatitis A virus genotype distribution in Estonia during 1994 to 2001. J Med Virol 70, 187193.[CrossRef][Medline]
Tanaka, J. (2000). Hepatitis A shifting epidemiology in Latin America. Vaccine 18 (Suppl. 1), S57S60.[CrossRef][Medline]
Tapia-Conyer, R., Santos, J. I., Cavalcanti, A. M., Urdaneta, E., Rivera, L., Manterola, A., Potin, M., Ruttiman, R. & Tanaka Kido, J. (1999). Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg 61, 825829.
Taylor, M. B. (1997). Molecular epidemiology of South African strains of hepatitis A virus: 19821996. J Med Virol 51, 273279.[CrossRef][Medline]
Ticehurst, J. R., Racaniello, V. R., Baroudy, B. M., Baltimore, D., Purcell, R. H. & Feinstone, S. M. (1983). Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A 80, 58855889.[Abstract]
Ticehurst, J. C., Cohen, J. I. & Purcell, R. H. (1988). Analysis of molecular sequences demonstrates that hepatitis A virus (HAV) is a unique picornavirus. In Viral Hepatitis and Liver Disease, pp. 3335. Edited by A. J. Zuckerman. New York: Alan R. Liss.
Tosh, C., Hemadri, D. & Sanyal, A. (2002). Evidence of recombination in the capsid-coding region of type A foot-and-mouth disease virus. J Gen Virol 83, 24552460.
Tsarev, S. A., Emerson, S. U., Balayan, M. S., Ticehurst, J. & Purcell, R. H. (1991). Simian hepatitis A virus (HAV) strain AGM-27: comparison of genome structure and growth in cell culture with other HAV strains. J Gen Virol 72, 16771683.[Abstract]
Venuti, A., Di Russo, C., del Grosso, N. & 13 other authors (1985). Isolation and molecular cloning of a fast-growing strain of human hepatitis A virus from its double-stranded replicative form. J Virol 56, 579588.[Medline]
Weitz, M. & Siegl, G. (1985). Variation among hepatitis A virus strains. I. Genomic variation detected by T1 oligonucleotide mapping. Virus Res 4, 5367.[CrossRef][Medline]
Worobey, M. & Holmes, E. C. (1999). Evolutionary aspects of recombination in RNA viruses. J Gen Virol 80, 25352543.
Worobey, M., Rambaut, A. & Holmes, E. C. (1999). Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A 96, 73527357.